Home Industries Market Insights About Us Publisher Contact us

Next-Generation Biomanufacturing Market By Product Type (Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products, Downstream Biomanufacturing Products) By Application (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins) By End User (Biopharmaceutical Companies, CMOS/CDMOs, Research Institutions) By Workflow (Upstream Biomanufacturing, Downstream Biomanufacturing) - Global Opportunity Analysis And Industry Forecast, 2021-2027

Categories: Life Science

Formate :

Global Next-Generation Biomanufacturing Market Overview 

The Global Next-Generation Biomanufacturing Market size is estimated to reach $83.8 Billion by 2026, growing at a CAGR of 15.4% over the forecast period of 2021-2026.

 

Next-generation biomanufacturing technologies enable stereo-specific product synthesis, with these synthesis reactions being easily adjusted. These procedures can also be cost-effective and ecologically favorable.

 

This paper discusses novel technologies for increasing yields and product attributes while avoiding the drawbacks of extensive extraction and purification operations. The major drivers for this market are increasing biologics and biosimilars approvals and a growing trend among biomanufacturing vendors to integrate automation technologies. Therefore, it helps in boosting the bioproduction workflow while reducing cost, time, and labor.

 

Impact of COVID-19 on Next-Generation Biomanufacturing Market

The expansion of the Next-Generation Biomanufacturing Market was hampered during COVID-19, particularly in 2020. Even though the interventional oncology clinics continued to function, the firms' revenues suffered a setback.

 

Key Takeaways from Global Next-Generation Biomanufacturing Market Report:

  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for a product, end-use, technology, applications, workflow, and by different industries verticals. Understand the market dynamics – key driving factors, challenges, and hidden opportunities.
  • Get in-depth insights on your competitor's performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT, and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep dive on the value augmentation at each step to optimize value and bring efficiencies in your processes. 
  • Get a quick outlook on the market entropy – M&As, deals, partnerships, product launches of all key players for the past 4 years. 
  • Evaluate the supply-demand gaps, import-export statistics, and regulatory landscape for more than the top 20 countries globally for the market.

 

Market Dynamics

Driver: 

Increasing biologics and biosimilar approvals is a key driver in Next-Generation Biomanufacturing Market

 

Biologics and biosimilars are increasingly getting approved by FDA because of their high safety and effectiveness. It has, in return, resulted in their contribution towards the next-generation biomanufacturing market.

 

Challenge: 

Lack of skilled professionals has resulted in a significant restraint in Next-Generation Biomanufacturing Market

 

The next-generation biomanufacturing market is predominantly a new field that has evolved recently. This factor makes it challenging to find skilled professionals who are well versed in handling this field. Hence this is affecting the growth of the next-generation biomanufacturing market.

 

By workflow, downstream biomanufacturing is estimated to grow at the highest CAGR during the forecast period.

Upstream biomanufacturing dominates the worldwide next-generation biomanufacturing industry in terms of workflow. It is due to the use of a considerable amount of high-cost equipment in upstream biomanufacturing instead of downstream biomanufacturing.

 

However, as compared to upstream biomanufacturing, downstream biomanufacturing is predicted to grow faster, with a CAGR of 16.1% over 2021-2026. It is primarily due to ongoing product improvements in the chromatography product lines and downstream processing filtration systems. 

 

Geographical Overview

The Asia Pacific to account for the largest market share during the forecast period

North America led the worldwide next-generation biomanufacturing market in 2020, outperforming all other regions with a share of 34.9%. The expansion of the next-generation biomanufacturing market in North America is being aided by large, well-equipped biomanufacturing facilities, modern infrastructure, and major investments in the biomanufacturing industry.

 

On the other hand, during the projected 2021-2026, Asia-Pacific is predicted to have the highest CAGR of all regions. It is primarily due to the high potential of Asia-Pacific growing nations such as Japan, India, Australia, South Korea, and Singapore, which are seeing widespread adoption of technologically advanced biomanufacturing equipment.

 

In addition, the increasing number of new capacity installations to suit rising product demand in Asia-Pacific emerging countries is predicted to enhance the market for next-generation biomanufacturing.

 

Key Market Players  

Key Players in Global Next-Generation Biomanufacturing Market consist of Applikon Biotechnology BV, bbi-biotech GmbH, Danaher Corporation, Eppendorf AG, Esco Group of Companies, GEA Group Aktiengesellschaft, Meissner Filtration Products, Inc., Merck KGaA, PBS Biotech, Inc., Pierre Guérin, Sartorius AG, Shanghai Bailun Biotechnology Co. Ltd., among others.

 

Developments

In February 2020, Honeywell International Inc. teamed up with Bigfinite, Inc. to contribute to process automation and controls technologies, using Bigfinite's AI, data analytics, and machine learning platform to assist the pharmaceutical and biotech sectors in pacing medicinal treatments.

 

Report Coverage and Scope

The report "Global Next-Generation Biomanufacturing Market" by Research Informatic covers an in-depth detailed analysis for the following segment, covered under the scope.

 

By Product

  • Continuous Upstream Biomanufacturing Products
  • Single-Use Upstream Biomanufacturing Products
  • Downstream Biomanufacturing Products

 

By Applications

  • Monoclonal Antibodies
  • Hormones
  • Vaccines
  • Recombinant Proteins

 

By Workflow

  • Upstream Biomanufacturing
  • Downstream Biomanufacturing

 

By End Users

  • Biopharmaceutical Companies
  • CMOS/CDMOs
  • Research Institutions

 

Geography

  • North America
  • Europe
  • APAC
  • RoW

 

 Chapter 1 Next-Generation Biomanufacturing Market Overview


1.1 Product Overview and Scope of Next-Generation Biomanufacturing


1.2 Next-Generation Biomanufacturing Market Segmentation By Product Type


1.2.1 Continuous Upstream Biomanufacturing Products


1.2.2 Single-Use Upstream Biomanufacturing Products


1.2.3 Downstream Biomanufacturing Products


1.3 Next-Generation Biomanufacturing Market Segmentation By Applications


1.3.1 Monoclonal Antibodies


1.3.2 Hormones


1.3.3 Vaccines


1.3.4 Recombinant Proteins


1.4 Next-Generation Biomanufacturing Market Segmentation by Regions


1.4.1 North America


1.4.2 China


1.4.3 Europe


1.4.4 Southeast Asia


1.4.5 Japan


1.4.6 India


1.5 Global Market Size (Value) of Next-Generation Biomanufacturing (2015-2027)


 


Chapter 2 Global Economic Impact on Next-Generation Biomanufacturing Industry


2.1 Global Macroeconomic Environment Analysis


2.1.1 Global Macroeconomic Analysis


2.1.2 Global Macroeconomic Environment Development Trend


2.2 Global Macroeconomic Environment Analysis by Regions


 


Chapter 3 Global Next-Generation Biomanufacturing Market Competition by Manufacturers


3.1 Global Next-Generation Biomanufacturing Production and Share by Manufacturers (2021 and 2021)


3.2 Global Next-Generation Biomanufacturing Revenue and Share by Manufacturers (2021 and 2021)


3.3 Global Next-Generation Biomanufacturing Average Price by Manufacturers (2021 and 2021)


3.4 Manufacturers Next-Generation Biomanufacturing Manufacturing Base Distribution, Production Area and Product Type


3.5 Next-Generation Biomanufacturing Market Competitive Situation and Trends


3.5.1 Next-Generation Biomanufacturing Market Concentration Rate


3.5.2 Next-Generation Biomanufacturing Market Share of Top 3 and Top 5 Manufacturers


3.5.3 Mergers & Acquisitions, Expansion


 


Chapter 4 Global Next-Generation Biomanufacturing Production, Revenue (Value) by Region (2015-2021)


4.1 Global Next-Generation Biomanufacturing Production by Region (2015-2021)


4.2 Global Next-Generation Biomanufacturing Production Market Share by Region (2015-2021)


4.3 Global Next-Generation Biomanufacturing Revenue (Value) and Market Share by Region (2015-2021)


4.4 Global Next-Generation Biomanufacturing Production, Revenue, Price and Gross Margin (2015-2021)


4.5 North America Next-Generation Biomanufacturing Production, Revenue, Price and Gross Margin (2015-2021)


4.6 Europe Next-Generation Biomanufacturing Production, Revenue, Price and Gross Margin (2015-2021)


4.7 China Next-Generation Biomanufacturing Production, Revenue, Price and Gross Margin (2015-2021)


4.8 Japan Next-Generation Biomanufacturing Production, Revenue, Price and Gross Margin (2015-2021)


4.9 Southeast Asia Next-Generation Biomanufacturing Production, Revenue, Price and Gross Margin (2015-2021)


4.10 India Next-Generation Biomanufacturing Production, Revenue, Price and Gross Margin (2015-2021)


 


Chapter 5 Global Next-Generation Biomanufacturing Supply (Production), Consumption, Export, Import by Regions (2015-2021)


5.1 Global Next-Generation Biomanufacturing Consumption by Regions (2015-2021)


5.2 North America Next-Generation Biomanufacturing Production, Consumption, Export, Import by Regions (2015-2021)


5.3 Europe Next-Generation Biomanufacturing Production, Consumption, Export, Import by Regions (2015-2021)


5.4 China Next-Generation Biomanufacturing Production, Consumption, Export, Import by Regions (2015-2021)


5.5 Japan Next-Generation Biomanufacturing Production, Consumption, Export, Import by Regions (2015-2021)


5.6 Southeast Asia Next-Generation Biomanufacturing Production, Consumption, Export, Import by Regions (2015-2021)


5.7 India Next-Generation Biomanufacturing Production, Consumption, Export, Import by Regions (2015-2021)


 


Chapter 6 Global Next-Generation Biomanufacturing Production, Revenue (Value), Price Trend by Type


6.1 Global Next-Generation Biomanufacturing Production and Market Share by Type (2015-2021)


6.2 Global Next-Generation Biomanufacturing Revenue and Market Share by Type (2015-2021)


6.3 Global Next-Generation Biomanufacturing Price by Type (2015-2021)


6.4 Global Next-Generation Biomanufacturing Production Growth by Type (2015-2021)


 


Chapter 7 Global Next-Generation Biomanufacturing Market Analysis by Application


7.1 Global Next-Generation Biomanufacturing Consumption and Market Share by Application (2015-2021)


7.2 Global Next-Generation Biomanufacturing Consumption Growth Rate by Application (2015-2021)


7.3 Market Drivers and Opportunities


7.3.1 Potential Applications


7.3.2 Emerging Markets/Countries


 


Chapter 8 Next-Generation Biomanufacturing Manufacturing Cost Analysis


8.1 Next-Generation Biomanufacturing Key Raw Materials Analysis


8.1.1 Key Raw Materials


8.1.2 Price Trend of Key Raw Materials


8.1.3 Key Suppliers of Raw Materials


8.1.4 Market Concentration Rate of Raw Materials


8.2 Proportion of Manufacturing Cost Structure


8.2.1 Raw Materials


8.2.2 Labour Cost


8.2.3 Manufacturing Expenses


8.3 Manufacturing Process Analysis of Nano Diamond Battery


 


Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers


9.1 Next-Generation Biomanufacturing Industrial Chain Analysis


9.2 Upstream Raw Materials Sourcing


9.3 Raw Materials Sources of Next-Generation Biomanufacturing Major Manufacturers in 2021


9.4 Downstream Buyers


 


Chapter 10 Marketing Strategy Analysis, Distributors/Traders


10.1 Marketing Channel


10.1.1 Direct Marketing


10.1.2 Indirect Marketing


10.1.3 Marketing Channel Development Trend


10.2 Market Positioning


10.2.1 Pricing Strategy


10.2.2 Brand Strategy


10.2.3 Target Client


10.3 Distributors/Traders List


 


Chapter 11 Market Effect Factors Analysis


11.1 Technology Progress/Risk


11.1.1 Substitutes Threat


11.1.2 Technology Progress in Related Industry


11.2 Consumer Needs/Customer Preference Change


11.3 Economic/Political Environmental Change


 


Chapter 12 Global Next-Generation Biomanufacturing Market Forecast (2021-2027)


12.1 Global Next-Generation Biomanufacturing Production, Revenue Forecast (2021-2027)


12.2 Global Next-Generation Biomanufacturing Production, Consumption Forecast by Regions (2021-2027)


12.3 Global Next-Generation Biomanufacturing Production Forecast by Type (2021-2027)


12.4 Global Next-Generation Biomanufacturing Consumption Forecast by Application (2021-2027)


12.5 Next-Generation Biomanufacturing Price Forecast (2021-2027)


 


Chapter 13 Appendix 

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

What is Next-Generation Biomanufacturing?

Next-generation biomanufacturing technologies enable stereo-specific product synthesis, with these synthesis reactions being easily adjusted. These procedures can also be cost-effective and ecologically favorable.

What is the Next-Generation Biomanufacturing market share?

The Global Next-Generation Biomanufacturing Market size is estimated to reach $83.8 Billion by 2026, growing at a CAGR of 15.4% over the forecast period of 2021-2026.

What are the key factors driving the Next-Generation Biomanufacturing Market?

Increasing biologics and biosimilar approvals is a key driver in Next-Generation Biomanufacturing Market. Biologics and biosimilars are increasingly getting approved by FDA because of their high safety and effectiveness. It has, in return, resulted in their contribution towards the next-generation biomanufacturing market.

What are the top companies in the Next-Generation Biomanufacturing Market?

Applikon Biotechnology BV, bbi-biotech GmbH, Danaher Corporation, Eppendorf AG, Esco Group of Companies, GEA Group Aktiengesellschaft, Meissner Filtration Products, Inc., Merck KGaA, PBS Biotech, Inc., Pierre Guérin, Sartorius AG, Shanghai Bailun Biotechnology Co. Ltd., among others.

In which Region the market is growing?

North America led the worldwide next-generation biomanufacturing market in 2020, outperforming all other regions with a share of 34.9%. The expansion of the next-generation biomanufacturing market in North America is being aided by large, well-equipped biomanufacturing facilities, modern infrastructure, and major investments in the biomanufacturing industry.

Which products have been included in Next-Generation Biomanufacturing market report?

Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products, Downstream Biomanufacturing Products.

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Next-Generation Biomanufacturing Market By Product...

RD Code : HP22